All companies
Fielmann Group AG logo

What smart money is saying about Fielmann Group AGGermany flag

FIE.DE · Healthcare · Medical Instruments & Supplies · Market cap $4.22B

1 fund in our archive has pitched Fielmann Group AG, most recently Tesys Value FI in September 2026.

Company profile

Fielmann Group AG engages in vision care and audiology business in Germany, Switzerland, Austria, Spain, North America, and internationally. The company manufactures and sells visual aids mainly glasses, eyewear frames and lenses, sunglasses, contact lenses, ready-made reading glasses, hearing systems and its accessories, as well as personal protective equipment. It also offers its products under the fielmann, Optika Clarus, Optica & Audiologia Universitaria, Medical optica audicion, Shopko Optical, and SVS VISION brand names. The company sells its products through digital sales, retail stores, as well as Befitting, an optical e-commerce platform. The company was formerly known as Fielmann Aktiengesellschaft and changed its name to Fielmann Group AG in July 2023. Fielmann Group AG was founded in 1972 and is headquartered in Hamburg, Germany. Fielmann Group AG operates as a subsidiary of Korva SE.

Get an email when a fund buys, sells or pitches it

Summarize with Warren AI
2
Reported positions
2
Bought
0
Sold
2
Letters

Position history

Every position in Fielmann Group AG on record in the archive was reported in Q3 2026, across 2 fund letters, with 2 buys (opened or added).

Fund letters reporting a position in Fielmann Group AG, by quarter
QuarterLettersBoughtSoldTheses
Q3 20262201

Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.

Fund activity · 2 positions · 2 moves

Fund coverage · 1 thesis

  • Tesys Value FI
    September 2026

    Fielmann grows profits and its 17% decline since first purchase comes from multiple contraction, with population aging and scale advantages intact.

    Read the full thesis

Read every full thesis on Fielmann Group AG

Read all 1 thesis in full, with each fund's reasoning, and get unlimited access to the archive.

View plans→
Share this ledger